Circulation

Vol. 152, Issue 24 Issue 24 2025
13
Articles

Articles in this Issue

Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade

Julian S. Wanner, Maren Krafft, Teemu Niiranen et al. Dec 16, 2025 pp. 1679-1690 10.1161/circulationaha.125.075057

BACKGROUND: Atrial fibrillation and other cardiac arrhythmias pose a major public health burden, but prevention remains difficult. We investigated a genetic variant that we found t...

Letter by Boccatonda et al Regarding Article, “A Randomized Controlled Trial of Thoracentesis in Acute Heart Failure”

Andrea Boccatonda, Damiano D’Ardes, Francesco Cipollone Dec 16, 2025 10.1161/circulationaha.125.075311

Acute Hemodynamic Effects of Sotatercept

Nils Kremer, Bruno R. Thal, Patrick Janetzko et al. Dec 16, 2025 pp. 1735-1738 10.1161/circulationaha.125.076913

High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial

Vivek Y. Reddy, Jacob S. Koruth, Petr Peichl et al. Dec 16, 2025 pp. 1691-1704 10.1161/circulationaha.125.077025

BACKGROUND: Unlike the tremendous progress made in atrial fibrillation ablation, the greatest unmet clinical need is for innovative ablation treatments for scar-related ventricular...

Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome

Sotirios Tsimikas, Michael Szarek, Christa M. Cobbaert et al. Dec 16, 2025 pp. 1666-1678 10.1161/circulationaha.125.073855

BACKGROUND: Oxidized phospholipids on apolipoprotein B-100 (OxPL-apoB) reflect pro-inflammatory properties of Lp(a) (lipoprotein(a)). The effect of OxPL-apoB on major adverse cardi...

Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy

Anton Xu, David Weissman, Katharina J. Ermer et al. Dec 16, 2025 pp. 1705-1727 10.1161/circulationaha.125.074120

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a prevalent inherited cardiac disorder marked by left ventricular hypertrophy and hypercontractility. This e...

Genetic and Genomic Testing in Cardiovascular Disease: A Policy Statement From the American Heart Association

Andrew P. Landstrom, Jane F. Ferguson, Cynthia A. James et al. Dec 16, 2025 10.1161/cir.0000000000001385

The rapid advancement of genomic and precision medicine has expanded the role of genetics and genomics in the diagnosis, risk stratification, and management of cardiovascular diseases. With the decrea...

Troponin Autoantibodies, Macrotroponin, and Assay Interference

Saara Wittfooth Dec 16, 2025 pp. 1663-1665 10.1161/circulationaha.125.076296

Hypertrophic Cardiomyopathy is a Disease of Altered Metabolism: Interdependence of Hypercontractility, Oxidative Stress, and Creatine Kinase Dysfunction

Daniel Bernstein, Giovanni Fajardo Dec 16, 2025 pp. 1728-1731 10.1161/circulationaha.125.077743

A Storm of Tachycardia Following Stroke: What Is the Mechanism?

Xinpei Wang, Huijian Liu, Qing Lu Dec 16, 2025 pp. 1732-1734 10.1161/circulationaha.125.078028

Letter by Lei et al Regarding Article, “A Randomized Controlled Trial of Thoracentesis in Acute Heart Failure”

Jiawei Lei, Fei Zhang, Jiahe Wang Dec 16, 2025 10.1161/circulationaha.125.075122

Response by Glargaard and Thune to Letters Regarding Article, “A Randomized Trial of Thoracentesis in Acute Heart Failure”

Signe Glargaard, Jens Jakob Thune Dec 16, 2025 10.1161/circulationaha.125.076838

Letter by Harris et al Regarding Article, “A Randomized Controlled Trial of Thoracentesis in Acute Heart Failure”

Benjamin R.E. Harris, Darlene R. Nelson, Ryan M. Kern Dec 16, 2025 10.1161/circulationaha.125.075533

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page